Log in

Relevant bibliographies by topics / Haemophilus pertussis / Journal articles

To see the other types of publications on this topic, follow the link: Haemophilus pertussis.

Journal articles on the topic 'Haemophilus pertussis'

Author: Grafiati

Published: 17 September 2021

Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Haemophilus pertussis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Billaudelle, Helmut. "STUDIEN AN HAEMOPHILUS PERTUSSIS (BORDET-GENGOU)." Acta Pathologica Microbiologica Scandinavica 35, no. 5 (2009): 458–68. http://dx.doi.org/10.1111/j.1699-0463.1954.tb00893.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

BILLAUDELLE, HELMUT. "STUDIEN AN HAEMOPHILUS PERTUSSIS (BORDET-GENGOU)." Acta Pathologica Microbiologica Scandinavica 37, no. 1 (2009): 5–13. http://dx.doi.org/10.1111/j.1699-0463.1955.tb00909.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

BILLAUDELLE, HELMUT. "STUDIEN AN HAEMOPHILUS PERTUSSIS (BORDET-GENGOU)." Acta Pathologica Microbiologica Scandinavica 37, no. 5 (2009): 434–40. http://dx.doi.org/10.1111/j.1699-0463.1955.tb00967.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

BILLAUDELLE, HELMUT. "STUDIEN AN HAEMOPHILUS PERTUSSIS (BORDET-GENGOU)." Acta Pathologica Microbiologica Scandinavica 37, no. 5 (2009): 441–48. http://dx.doi.org/10.1111/j.1699-0463.1955.tb00968.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

BRUNELL, PHILIP A. "Prevention of pertussis, Haemophilus and varicella infections." Pediatric Infectious Disease Journal 4, no. 4 (1985): 439–41. http://dx.doi.org/10.1097/00006454-198507000-00051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hülße, C. "Tetanus, diphtheria, pertussis, haemophilus influenzae b, poliomyelitis." Der Gynäkologe 33, no. 8 (2000): 565–73. http://dx.doi.org/10.1007/s001290050603.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Eskola, Juhani, Joel Ward, Ron Dagan, David Goldblatt, Fred Zepp, and Claire-Anne Siegrist. "Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis." Lancet 354, no. 9195 (1999): 2063–68. http://dx.doi.org/10.1016/s0140-6736(99)04377-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sikora, Janusz Piotr, Danuta Chlebna-Sokół, Iwona Ligenza, and Anna Sikora. "Haemophilus influenzae type b and pertussis vaccinations in preterm infants." Archivum Immunologiae et Therapiae Experimentalis 54, no. 3 (2006): 193–99. http://dx.doi.org/10.1007/s00005-006-0020-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Niederman, L. Gerard, and John F. Marcinak. "HAEMOPHILUS INFLUENZAE TYPE B ABSCESS AFTER DIPHTHERIA-TETANUS TOXOIDS-PERTUSSIS IMMUNIZATION." Pediatric Infectious Disease Journal 9, no. 8 (1990): 597. http://dx.doi.org/10.1097/00006454-199008000-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

PETER, GEORGES, Michael W. Simon, and Robert S. Daum. "EFFICACY OF THE COMBINED DIPHTHERIA-TETANUS TOXOIDS-PERTUSSIS-HAEMOPHILUS CONJUGATE VACCINE." Pediatric Infectious Disease Journal 14, no. 7 (1995): 640. http://dx.doi.org/10.1097/00006454-199507000-00029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

PARADISO, PETER R. "Combination Vaccines for Diphtheria, Tetanus, Pertussis, and Haemophilus influenzae Type b." Annals of the New York Academy of Sciences 754, no. 1 Combined Vacc (1995): 108–13. http://dx.doi.org/10.1111/j.1749-6632.1995.tb44443.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

LAUBEREAU, B., M. HERMANN, H. J. SCHMITT, J. WEIL, and R. VON KRIES. "Detection of delayed vaccinations: a new approach to visualize vaccine uptake." Epidemiology and Infection 128, no. 2 (2002): 185–92. http://dx.doi.org/10.1017/s0950268801006550.

Full text

Abstract:

For the prevention of pertussis and invasive Haemophilus influenzae type b (Hib) infections, each with a peak for mortality and serious complications in the first year of life, early vaccination is important and needs adequate monitoring. In a 1999 national coverage survey the timing of uptake of these vaccines in German children was therefore assessed conventionally at defined age thresholds and with a new adaptation of the Kaplan–Meier (KM) method estimating immunization uptake over time by 1 minus the survival function s(t). Only 6% and 9% of children were vaccinated against pertussis and H

APA, Harvard, Vancouver, ISO, and other styles

13

Glismann, S., T. Rønne, and A. E. Tozzi. "The EUVAC-NET project: creation and operation of a surveillance community network for vaccine preventable infectious diseases." Eurosurveillance 6, no. 6 (2001): 94–98. http://dx.doi.org/10.2807/esm.06.06.00204-en.

Full text

Abstract:

The EUVAC-NET network is in charge of the epidemiological surveillance and control of vaccine preventable diseases. It is coordinated by the SSI in Denmark, in collaboration with the ISS in Italy. The two main diseases targeted by the network are measles and pertussis. A collaboration is planned with the PHLS for the monitoring of Haemophilus influenzae b. EUVAC-NET includes the Member States of the European Union, and Iceland, Norway and Switzerland.

APA, Harvard, Vancouver, ISO, and other styles

14

Alonso, Sylvie, Eve Willery, Genevieve Renauld-Mongénie, and Camille Locht. "Production of Nontypeable Haemophilus influenzae HtrA by Recombinant Bordetella pertussis with the Use of Filamentous Hemagglutinin as a Carrier." Infection and Immunity 73, no. 7 (2005): 4295–301. http://dx.doi.org/10.1128/iai.73.7.4295-4301.2005.

Full text

Abstract:

ABSTRACT Bordetella pertussis, the etiologic agent of whooping cough, is a highly infectious human pathogen capable of inducing mucosal and systemic immune responses upon a single intranasal administration. In an attenuated, pertussis toxin (PTX)-deficient recombinant form, it may therefore constitute an efficient bacterial vector that is particularly well adapted for the delivery of heterologous antigens to the respiratory mucosa. Filamentous hemagglutinin (FHA) has been used as a carrier to present foreign antigens at the bacterial surface, thereby inducing local, systemic, and protective im

APA, Harvard, Vancouver, ISO, and other styles

15

Gómez-de-León, Patricia, F. Javier Díaz-García, Alberto Villaseñor-Sierra, et al. "Immunoglobulin G Avidities in Infants in Mexico after Primary Immunization with Three Doses of Polyribosylribitol Phosphate-Tetanus Toxoid Haemophilus influenzae Type b Vaccine." Clinical and Vaccine Immunology 15, no. 6 (2008): 1024–27. http://dx.doi.org/10.1128/cvi.00009-08.

Full text

Abstract:

ABSTRACT Serum immunoglobulin G concentrations and avidities specific to Haemophilus influenzae type b (Hib) were measured in 208 children living in Guadalajara and Mexico City. Protective concentrations were found in 98.9% and 100.0% of participants, respectively. Geometric mean concentrations differed between both populations and/or among age groups. Mean avidities differed only among the 7- to 12-month-old children. Diphtheria-tetanus-whole-cell pertussis-hepatitis B-Hib primary vaccination seems to induce protection in Mexican children.

APA, Harvard, Vancouver, ISO, and other styles

16

Bertoncello, Chiara, Annamaria Nicolli, Stefano Maso, et al. "Uptake of Non-Mandatory Vaccinations in Future Physicians in Italy." Vaccines 9, no. 9 (2021): 1035. http://dx.doi.org/10.3390/vaccines9091035.

Full text

Abstract:

In 2017 in Italy, a number of vaccinations became mandatory or started to be recommended and offered free of charge. In this study, we aimed at assessing the coverage rates for those vaccinations in the pre-mandatory era among students at the School of Medicine of Padua University studying the degree course in medicine and surgery (future physicians) on the basis of the vaccination certificates presented during health surveillance. The vaccinations considered were those against pertussis, rubella, mumps, measles, varicella, Haemophilus influenzae type b (which became mandatory in 2017), pneumo

APA, Harvard, Vancouver, ISO, and other styles

17

Jäger-Becker, Dagmar. "Grundimmunisierung und Auffrischimpfungen bleiben wichtig." Kinder- und Jugendmedizin 18, no. 01 (2018): 61. http://dx.doi.org/10.1055/s-0038-1637815.

Full text

Abstract:

Da besonders Säuglinge durch Keuchhusten gefährdet sind, ist ein frühzeitiger Impfschutz angeraten. Die STIKO empfiehlt die Grundimmunisierung von Säuglingen und Kleinkindern gegen Diphtherie, Tetanus, Pertussis, Poliomyelitis und Hepatitis B sowie gegen Haemophilus-influenzae-Typ-b (Hib) nach dem Schema 3 + 1: drei Impfungen im Alter von 2–4 Monaten, jeweils im Abstand von mindestens vier Wochen. Die letzte Impfung einer Grundimmunisierung wird im Alter von 11–14 Monaten gegeben. Mit dem Sechsfach-Impfstoff Hexyon® können Säuglinge ab einem Alter von sechs Wochen so immunisiert werden. Studie

APA, Harvard, Vancouver, ISO, and other styles

18

Bell, F., A. Martin, C. Blondeau, C. Thornton, J. Chaplais, and A. Finn. "Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation." Archives of Disease in Childhood 75, no. 4 (1996): 298–303. http://dx.doi.org/10.1136/adc.75.4.298.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Antona, D., E. Bussière, N. Guignon, G. Badeyan, and D. Lévy-Bruhl. "Vaccine coverage of pre-school age children in France in 2000." Eurosurveillance 8, no. 6 (2003): 139–44. http://dx.doi.org/10.2807/esm.08.06.00417-en.

Full text

Abstract:

This article presents results of the main measures on vaccine coverage carried out in France in children up to six years of age. Vaccine coverage is very high for diphtheria, tetanus, pertussis, and poliomyelitis, and satisfactory for vaccination against Haemophilus influen-zae b invasive infections. It will be necessary, however, to increase vaccine coverage against measles, mumps and rubella in infants and to ensure efficient catch up. Hepatitis B vaccine coverage is deficient in infants and could be improved when the vaccine is available in a combined form.

APA, Harvard, Vancouver, ISO, and other styles

20

Greenberg, David P., Martha Doemland, Julie A. Bettinger, et al. "Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine." Pediatric Infectious Disease Journal 28, no. 6 (2009): 521–28. http://dx.doi.org/10.1097/inf.0b013e318199d2fc.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Denoël, Philippe A., David Goldblatt, Isabel de Vleeschauwer, Jeanne-Marie Jacquet, Michael E. Pichichero, and Jan T. Poolman. "Quality of the Haemophilus influenzae Type b (Hib) Antibody Response Induced by Diphtheria-Tetanus-Acellular Pertussis/Hib Combination Vaccines." Clinical and Vaccine Immunology 14, no. 10 (2007): 1362–69. http://dx.doi.org/10.1128/cvi.00154-07.

Full text

Abstract:

ABSTRACT It has been repeatedly observed that mixing Haemophilus influenzae type b (Hib) conjugate vaccines with acellular pertussis-containing vaccines (diphtheria-tetanus-acellular pertussis [DTPa]) resulted in a reduced magnitude of the anti-polyriboseribitolphosphate antibody response compared to that obtained when Hib vaccines were administered separately and not mixed. Nevertheless, the quality and functionality of the immune responses have been shown to be the same. With the purpose of investigating the quality of the anti-Hib immune responses that are elicited under different vaccinati

APA, Harvard, Vancouver, ISO, and other styles

22

ROBLOT, F., S. ROBIN, C. CHUBILLEAU, J. GIRAUD, B. BOUFFARD, and P. INGRAND. "Vaccination coverage in French 17-year-old young adults: an assessment of mandatory and recommended vaccination statuses." Epidemiology and Infection 144, no. 3 (2015): 612–17. http://dx.doi.org/10.1017/s0950268815001533.

Full text

Abstract:

SUMMARYWe aimed to assess vaccination coverage (VC) in 17-year-old French young adults (YAs) participating in one mandatory Day of Defence and Citizenship (DDC). Between June 2010 and May 2011, YAs participating in 43 randomly selected mandatory sessions of the DDC programme in Poitou-Charentes (France) were asked to provide their personal vaccination record. Tetanus, diphtheria, polio, hepatitis B, Haemophilus influenzae b, pertussis, measles, mumps and rubella vaccination status were assessed at ages 2, 6, 13 and 17 years. Of 2610 participants, 2111 (81%) supplied documents for evaluation. O

APA, Harvard, Vancouver, ISO, and other styles

23

Hogerman, Deborah A., and Peter R. Paradiso. "SAFETY AND EFFICACY OF DIPHTHERIA-TETANUS TOXOIDS-PERTUSSIS-HAEMOPHILUS INFLUENZAE TYPE b COMBINATION VACCINE." Pediatric Infectious Disease Journal 14, no. 12 (1995): 1121. http://dx.doi.org/10.1097/00006454-199512000-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Samore, M. H., and G. R. Siber. "Effect of Pertussis Toxin on Susceptibility of Infant Rats to Haemophilus influenzae Type b." Journal of Infectious Diseases 165, no. 5 (1992): 945–48. http://dx.doi.org/10.1093/infdis/165.5.945.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Clemens, SueAnn Costa, Tania Azevedo, and Akira Homma. "Feasibility study of the immunogenicity and safety of a novel DTPw/Hib (PRP-T) Brazilian combination compared to a licensed vaccine in healthy children at 2, 4, and 6 months of age." Revista da Sociedade Brasileira de Medicina Tropical 36, no. 3 (2003): 321–30. http://dx.doi.org/10.1590/s0037-86822003000300002.

Full text

Abstract:

Vaccination of infants with conjugated Haemophilus influenzae type b (Hib) vaccines has been proven to reduce Hib meningitis by 95% and pneumoniae by 20%. The routine use of Hib vaccine is facilitated by the introduction of combination vaccines into the EPI (Expanded Plan of Immunization). The objective of this study was to compare the immunogenicity and reactogenicity of an extemporaneously mixed DTPw/Hib (diphtheria-tetanus-whole cell pertussis) combination, using the technology of two Brazilian manufacturers, against a licensed DTPw/Hib European combination in 108 infants vaccinated at 2, 4

APA, Harvard, Vancouver, ISO, and other styles

26

Pichichero, Michael E., Timothy Voloshen, and Sherry Passador. "KINETICS OF BOOSTER RESPONSES TO HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE AFTER COMBINED DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-HAEMOPHILUS INFLUENZAE TYPE b VACCINATION IN INFANTS." Pediatric Infectious Disease Journal 18, no. 12 (1999): 1106–8. http://dx.doi.org/10.1097/00006454-199912000-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

McVernon, J., N. Andrews, MPE Slack, and ME Ramsay. "Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis." Lancet 361, no. 9368 (2003): 1521–23. http://dx.doi.org/10.1016/s0140-6736(03)13171-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Ambrosino, D. M., M. P. Glode, C. L. Williams, and G. R. Siber. "Antibody Response of Infants to Haemophilus influenzae Type b Capsular Polysaccharide Combined with Bordetella pertussis." Journal of Infectious Diseases 151, no. 6 (1985): 1174. http://dx.doi.org/10.1093/infdis/151.6.1174.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Gold, Ronald, Luis Barreto, Santiago Ferro, et al. "Safety and Immunogenicity of a Fully Liquid Vaccine Containing Five-Component Pertussis-Diphtheria-Tetanus-Inactivated Poliomyelitis-Haemophilus influenzaeType B Conjugate Vaccines Administered at Two, Four, Six and 18 Months of Age." Canadian Journal of Infectious Diseases and Medical Microbiology 18, no. 4 (2007): 241–48. http://dx.doi.org/10.1155/2007/289842.

Full text

Abstract:

OBJECTIVE: The safety, immunogenicity and lot consistency of a fully liquid, five-component acellular pertussis combination vaccine, comprised of diphteria, tetanus and acellular pertussis, inactivated polio vaccine,Haemophilus influenzaetype b (DTaP-IPV-Hib [Pediacel, sanofi pasteur, Canada]) were assessed and compared with that of Hib vaccine reconstituted with the five-component acellular pertussis combination vaccine (DTaP-IPV//Hib, Pentacel [sanofi pasteur, Canada]).METHODS: Infants were recruited at vaccine study centres in Montreal, Quebec; Simon Fraser Health Region, British Columbia,

APA, Harvard, Vancouver, ISO, and other styles

30

Ward, Christine K., Sheryl R. Lumbley, Jo L. Latimer, Leslie D. Cope, and Eric J. Hansen. "Haemophilus ducreyi Secretes a Filamentous Hemagglutinin-Like Protein." Journal of Bacteriology 180, no. 22 (1998): 6013–22. http://dx.doi.org/10.1128/jb.180.22.6013-6022.1998.

Full text

Abstract:

ABSTRACT We have identified two extremely large open reading frames (ORFs) in Haemophilus ducreyi 35000, lspA1 andlspA2, each of which encodes a predicted protein product whose N-terminal half is approximately 43% similar to the N-terminal half of Bordetella pertussis filamentous hemagglutinin (FhaB). To the best of our knowledge, lspA1 (12,500 nucleotides [nt]) and lspA2 (14,800 nt) are among the largest prokaryotic ORFs identified to date. The predicted proteins, LspA1 and LspA2, are 86% identical overall to each other and also have limited amino acid sequence similarity at their N termini t

APA, Harvard, Vancouver, ISO, and other styles

31

Ward, Christine K., Jason R. Mock, and Eric J. Hansen. "The LspB Protein Is Involved in the Secretion of the LspA1 and LspA2 Proteins by Haemophilus ducreyi." Infection and Immunity 72, no. 4 (2004): 1874–84. http://dx.doi.org/10.1128/iai.72.4.1874-1884.2004.

Full text

Abstract:

ABSTRACT The LspA1 and LspA2 proteins of Haemophilus ducreyi 35000 are two very large macromolecules that can be detected in concentrated culture supernatant fluid. Both of these proteins exhibit homology with the N-terminal region of the Bordetella pertussis filamentous hemagglutinin (FHA), which is involved in secretion of the latter macromolecule. The lspA2 open reading frame is flanked upstream by a gene, lspB, that encodes a predicted protein with homology to the B. pertussis FhaC outer membrane protein that is involved in secretion of FHA across the outer membrane. The H. ducreyi lspB ge

APA, Harvard, Vancouver, ISO, and other styles

32

Bauwens, Jorgen, Luis-Henri Saenz, Annina Reusser, Nino Künzli, and Jan Bonhoeffer. "Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature Review." Vaccines 8, no. 1 (2019): 12. http://dx.doi.org/10.3390/vaccines8010012.

Full text

Abstract:

The growing number of available vaccines that can be potentially co-administered makes the assessment of the safety of vaccine co-administration increasingly relevant but complex. We aimed to synthesize the available scientific evidence on the safety of vaccine co-administrations in children by performing a systematic literature review of studies assessing the safety of vaccine co-administrations in children between 1999 and 2019, in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Fifty studies compared co-administered vaccines versus the same

APA, Harvard, Vancouver, ISO, and other styles

33

Finn, Adam, Christine Blondeau, and Frank Bell. "Haemophilus influenzaeType B (Hib) Antibody Responses in Children Given Diphtheria‐Tetanus–Acellular Pertussis–Hib Combination Vaccines." Journal of Infectious Diseases 181, no. 6 (2000): 2117–18. http://dx.doi.org/10.1086/315511.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Redhead, Keith, Dorothea Sesardic, Susan E. Yost, et al. "Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests." Vaccine 12, no. 15 (1994): 1460–66. http://dx.doi.org/10.1016/0264-410x(94)90156-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Novaes, Mario Lucio de Oliveira, Renan Moritz Varnier Rodrigues de Almeida, and Ronaldo Rocha Bastos. "Assessing vaccine data recording in Brazil." Revista Brasileira de Epidemiologia 18, no. 4 (2015): 745–56. http://dx.doi.org/10.1590/1980-5497201500040006.

Full text

Abstract:

ABSTRACT: Objectives: Vaccines represent an important advancement for improving the general health of a population. The effective recording of vaccine data is a factor for the definition of its supply chain. This study investigated vaccine data recording relatively to data collected from vaccination rooms and data obtained from a government-developed Internet platform. Methods: The monthly recorded total number of diphtheria and tetanus toxoids and pertussis vaccine (alone or in combination with the Haemophilus influenzae type b conjugate vaccine) doses administered in a medium-sized city of t

APA, Harvard, Vancouver, ISO, and other styles

36

Saqib, Muhammad Arif Nadeem, Ibrar Rafique, Obaid Ullah, et al. "Protection against Haemophilus influenzae Type B, Diphtheria, and Tetanus in Children from Major Cities of Pakistan: A Community-Based Study." Journal of Pediatric Infectious Diseases 15, no. 04 (2020): 163–68. http://dx.doi.org/10.1055/s-0040-1702217.

Full text

Abstract:

Abstract Objective Pentavalent vaccine has been introduced in Pakistan against tetanus, diphtheria, Haemophilus influenzae type B (HiB), pertussis, and hepatitis B virus. Methods This study was designed to determine protection against diphtheria, tetanus, and HiB in children of age 18 to 24 months from community which had received all three doses of pentavalent vaccine. Results Overall, 97% were having immunity against HiB, 97% against tetanus, and 88% against diphtheria. Our study showed that children aged 18 to 24 months in Pakistan have high level of protection against HiB and tetanus. Howe

APA, Harvard, Vancouver, ISO, and other styles

37

Khalil, M. K., Y. Y. Al Mazrou, and Y. S. Al Ghamdi. "Vaccines: World Health Organization versus Federal Drug Administration recommended formula." Eastern Mediterranean Health Journal 6, no. 4 (2000): 644–51. http://dx.doi.org/10.26719/2000.6.4.644.

Full text

Abstract:

Vaccines produced in accordance with WHO formulas, differ in concentration from those used in United States according to FDA formulas. We aimed to compare the immunogenicity of both formulas. Infants who were 6 weeks old were randomly put into 3 groups to receive 3 doses of vaccines at 6 weeks, 3 months and 5 months of age. The vaccines consisted of Haemophilus influenzae type b vaccine, diphtheria-tetanus-pertussis and oral polio vaccine. Antibody levels for polyribosylribitol phosphate [PRP], tetanus, diphtheria and poliovirus were measured 1 month after the third dose of vaccines. Although

APA, Harvard, Vancouver, ISO, and other styles

38

Andrews, Nick, Julia Stowe, Lesley Wise, and Elizabeth Miller. "Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom." Vaccine 28, no. 44 (2010): 7215–20. http://dx.doi.org/10.1016/j.vaccine.2010.08.062.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Pickering, Larry K., Carol J. Baker, Gary L. Freed, et al. "Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America." Clinical Infectious Diseases 49, no. 6 (2009): 817–40. http://dx.doi.org/10.1086/605430.

Full text

Abstract:

Abstract Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These updated guidelines replace the previous immunization guidelines published in 2002. These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Since 2002, the capacity to prevent more infectious diseases has increased markedly for several reasons: new vaccines have been licensed (human papillomavirus vaccine; live, attenuated

APA, Harvard, Vancouver, ISO, and other styles

40

Manley, Jennifer, and Anna Taddio. "Acetaminophen and Ibuprofen for Prevention of Adverse Reactions Associated with Childhood Immunization." Annals of Pharmacotherapy 41, no. 7-8 (2007): 1227–32. http://dx.doi.org/10.1345/aph.1h647.

Full text

Abstract:

Objective: To evaluate the literature examining prophylactic use of acetaminophen and ibuprofen for prevention of adverse reactions associated with childhood immunization. Data Sources: Articles were identified via MEDLINE/PubMed/EMBASE (1966–March 2007) using the following key terms: vaccination, immunization, diphtheria–tetanus toxoids–whole pertussis (DTwP), diphtheria tetan us–toxoid. whole pertussis, diphtheria-tetanus toxoids–acellular pertussis (DTaP), acellular pertussis, Haemophilus influenzae type B, inactivated poliovirus, pneumococcal 7-valent conjugate, measles, mumps, rubella, me

APA, Harvard, Vancouver, ISO, and other styles

41

LOWTHER, S. A., N. SHINODA, B. A. JUNI, et al. "Haemophilus influenzaetype b infection, vaccination, andH. influenzaecarriage in children in Minnesota, 2008–2009." Epidemiology and Infection 140, no. 3 (2011): 566–74. http://dx.doi.org/10.1017/s0950268811000793.

Full text

Abstract:

SUMMARYAn increase in invasiveHaemophilus influenzaetype b (Hib) cases occurred in Minnesota in 2008 after the recommended deferral of the 12–15 months Hib vaccine boosters during a US vaccine shortage. Five invasive Hib cases (one death) occurred in children; four had incomplete Hib vaccination (three refused/delayed); one was immunodeficient. Subsequently, we evaluated Hib carriage and vaccination. From 18 clinics near Hib cases, children (aged 4 weeks–60 months) were surveyed for pharyngeal Hib carriage. Records were compared for Hib, diphtheria-tetanus-acellular pertussis (DTaP), and pneum

APA, Harvard, Vancouver, ISO, and other styles

42

Baldo, Vincenzo, Paolo Bonanni, Marcela Castro, et al. "Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzaetype b vaccine; Infanrix™ hexa." Human Vaccines & Immunotherapeutics 10, no. 1 (2013): 129–37. http://dx.doi.org/10.4161/hv.26269.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Levine, O. S., R. Lagos, G. A. Losonsky, et al. "No Adverse Impact on Protection against Pertussis from Combined Administration of Haemophilus infiuenzae Type b Conjugate and Diphtheria-Tetanus Toxoid-Pertussis Vaccines in the Same Syringe." Journal of Infectious Diseases 174, no. 6 (1996): 1341–44. http://dx.doi.org/10.1093/infdis/174.6.1341.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Trollfors, Birger, Lars Burman, Teresa Lagergård, Maija Leinonen, and John Taranger. "NO CROSS-REACTIVITY WITH FILAMENTOUS HEMAGGLUTININ OF BORDETELLA PERTUSSIS IN SERA FROM PATIENTS WITH NONTYPABLE HAEMOPHILUS INFLUENZAE PNEUMONIA." Pediatric Infectious Disease Journal 15, no. 6 (1996): 558–59. http://dx.doi.org/10.1097/00006454-199606000-00029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

de Voer, Richarda M., Fiona R. M. van der Klis, Judith E. Nooitgedagt, et al. "Seroprevalence and Placental Transportation of Maternal Antibodies Specific forNeisseria meningitidisSerogroup C,Haemophilus influenzaeType B, Diphtheria, Tetanus, and Pertussis." Clinical Infectious Diseases 49, no. 1 (2009): 58–64. http://dx.doi.org/10.1086/599347.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

MADORE, DACE V. "Progress and Challenges for a New Combination Vaccine Composed of Diphtheria, Tetanus, Acellular Pertussis, and Haemophilus b Conjugate." Annals of the New York Academy of Sciences 754, no. 1 Combined Vacc (1995): 356–58. http://dx.doi.org/10.1111/j.1749-6632.1995.tb44469.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Ward, J. I., G. Brenneman, M. Lepow, M. Lum, K. Burkhart, and C. Y. Chiu. "Haemophilus influenzae Type b Anticapsular Antibody Responses to PRP-Pertussis and PRP-D Vaccines in Alaska Native Infants." Journal of Infectious Diseases 158, no. 4 (1988): 719–23. http://dx.doi.org/10.1093/infdis/158.4.719.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

NICOL, MARK, ROBIN HUEBNER, ROSALIA MOTHUPI, HELENA KÄYHTY, NONTOMBI MBELLE, and ESTHER KHOMO. "Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: a randomized trial." Pediatric Infectious Disease Journal 21, no. 2 (2002): 138–41. http://dx.doi.org/10.1097/00006454-200202000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Kassim, Olakunle O., David H. Raphael, Ajibade K. Ako-Nai, Olufisan Taiwo, Spencer E. A. Torimiro, and Oladapo O. Afolabi. "Class-specific antibodies toBordetella pertussis, Haemophilus influenzaetype b,Streptococcus pneumoniaeandNeisseria meningitidisin human breast-milk and maternal-infant sera." Annals of Tropical Paediatrics 9, no. 4 (1989): 226–32. http://dx.doi.org/10.1080/02724936.1989.11748637.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Friedland, Leonard. "Vaccination in Older Adults: The Who and What." Innovation in Aging 4, Supplement_1 (2020): 806. http://dx.doi.org/10.1093/geroni/igaa057.2927.

Full text

Abstract:

Abstract Aging brings increased impact of infectious disease in terms of hospitalization, morbidity, and mortality. This increased susceptibility to infection results from immunosenescence, age-related changes in the immune system, anatomic and functional changes, and environmental exposure to infections. Adults age 65 and over are at increased risk of pertussis, shingles, influenza and pneumococcal disease, and evidence-based recommendations for vaccination are protect older adults against these diseases. Underlying medical conditions including end stage renal disease, chronic lung, heart and

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!